DVAX Insider Trading
Insider Ownership Percentage: 2.98%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $43,126.95
Dynavax Technologies Insider Trading History Chart
This chart shows the insider buying and selling history at Dynavax Technologies by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Dynavax Technologies Share Price & Price History
Current Price: $9.41
Price Change: ▼ Price Decrease of -0.28 (-2.89%)
As of 05/9/2025 04:59 PM ET
Dynavax Technologies Insider Trading History
Dynavax Technologies Institutional Trading History
Data available starting January 2016
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.
Read More on Dynavax Technologies
Volume
2,027,642 shs
Average Volume
2,216,042 shs
Market Capitalization
$1.13 billion
P/E Ratio
52.28
Dividend Yield
N/A
Beta
1.26
Who are the company insiders with the largest holdings of Dynavax Technologies?
Who are the major institutional investors of Dynavax Technologies?
Which institutional investors are selling Dynavax Technologies stock?
During the last quarter, DVAX stock was sold by these institutional investors:
- Vanguard Group Inc.
- Jefferies Financial Group Inc.
- Royce & Associates LP
- Bank of New York Mellon Corp
- Chicago Capital LLC
- Exchange Traded Concepts LLC
- Victory Capital Management Inc.
- SG Americas Securities LLC
Which institutional investors are buying Dynavax Technologies stock?
Within the previous quarter, DVAX stock was purchased by institutional investors including:
- GAMMA Investing LLC
- Advisor Resource Council
- XTX Topco Ltd
- Chicago Partners Investment Group LLC
- Bryce Point Capital LLC
- Cambridge Investment Research Advisors Inc.
- Pacer Advisors Inc.
- Peregrine Capital Management LLC